Web-Based Dissemination of Evidence-Based Prevention to U.S. Military

通过网络向美国军方传播循证预防

基本信息

项目摘要

DESCRIPTION (provided by applicant): This Phase I SBIR grant application requests six months of funding to develop and feasibility test an innovative Web-based distribution channel for increasing the dissemination, adoption, implementation, and sustainability (DAIS) of evidence-based substance use prevention programs to United States military personnel. Substance use and abuse, particularly heavy alcohol and tobacco use, remain problematic in the military and adversely affect health, safety, military fitness levels, deployment readiness, active service, and increase health care costs. Significant progress has been made in the development and testing of evidence-based prevention programs (EBPPs); however, these programs are underutilized in military settings. A systematic mechanism is needed to disseminate EBPPs to key military decision-makers. Alcohol and Drug Control Officers (ADCOs) and similar personnel oversee the provision of a variety of programs and services to military personnel and are important decision-makers in military settings. Indeed, ADCOs and related personnel have great potential to become dissemination agents and program champions for EBPPs. Accordingly, the goal of this proposed project is to develop a Web-based distribution channel for ADCOs and related personnel that will facilitate the DAIS of EBPPs to military personnel. In the proposed Phase I project, we will develop prototypes of the key components of the Web-based distribution channel, which will include informational resources on evidence- based programs, training and technical assistance resources to facilitate the implementation and sustainability of programs, a marketing toolkit, an electronic newsletter, and a decision support mechanism. Prevention programs for the workplace will be featured. Prior to prototype development, we will conduct key informant interviews with ADCOs from the Army to obtain input regarding ways to optimize the distribution channel components to meet the needs of local Army personnel. Following prototype development, we will conduct focus groups with ADCOs currently serving new recruits and young adult Army personnel to obtain their feedback regarding the feasibility and utility of the components in facilitating the DAIS of EBPPs. In Phase II, we will fully develop and populate the Web-based components and conduct a large-scale effectiveness trial involving the five branches of the U.S. military (Army, Navy, Marine Corps, Air Force, and Coast Guard). PUBLIC HEALTH RELEVANCE: This project involves the development and feasibility testing of a technology-based distribution channel for increasing the dissemination, adoption, implementation, and sustainability (DAIS) of evidence-based substance use prevention programs to service providers for United States Military personnel. Incorporating input from Alcohol and Drug Control Officers (ADCOs) from the US Army, as well as from an expert military psychologist, a prototype of a multi-component, Web-based distribution channel will be developed and populated with information about evidence-based workplace prevention programming. The feasibility and utility of the components will be focus group tested among ADCOs currently serving new recruits and young adult Army personnel in terms of the utility of the components in facilitating the DAIS of evidence-based programs.
描述(由申请人提供):第一阶段 SBIR 拨款申请需要六个月的资金来开发和可行性测试基于网络的创新分销渠道,以提高循证物质使用的传播、采用、实施和可持续性 (DAIS)针对美国军事人员的预防计划。药物使用和滥用,特别是酗酒和吸烟,在军队中仍然存在问题,并对健康、安全、军人体能水平、部署准备、现役服役产生不利影响,并增加医疗保健成本。循证预防计划(EBPP)的开发和测试取得了重大进展;然而,这些方案在军事环境中并未得到充分利用。需要一种系统机制来向关键军事决策者传播 EBPP。酒精和药物管制官员 (ADCO) 和类似人员负责监督向军事人员提供的各种计划和服务,并且是军事环境中的重要决策者。事实上,ADCO 和相关人员具有成为 EBPP 传播代理人和项目倡导者的巨大潜力。因此,该拟议项目的目标是为 ADCO 和相关人员开发一个基于网络的分发渠道,以促进军事人员的 EBPP DAIS。在拟议的第一阶段项目中,我们将开发基于网络的分销渠道的关键组件的原型,其中将包括有关基于证据的计划的信息资源、培训和技术援助资源以促进计划的实施和可持续性、营销工具包、电子通讯和决策支持机制。工作场所的预防计划将成为重点。在原型开发之前,我们将与陆军 ADCO 进行关键知情人访谈,以获取有关如何优化分销渠道组件以满足当地陆军人员需求的意见。原型开发完成后,我们将与目前为新兵和年轻成年陆军人员服务的 ADCO 进行焦点小组讨论,以获取他们对促进 EBPP DAIS 各组件的可行性和实用性的反馈。在第二阶段,我们将全面开发和填充基于网络的组件,并进行涉及美国军队五个军种(陆军、海军、海军陆战队、空军和海岸警卫队)的大规模有效性试验。 公共卫生相关性:该项目涉及基于技术的分销渠道的开发和可行性测试,以提高向美国军事人员的服务提供商传播、采用、实施和可持续性(DAIS)基于证据的药物使用预防计划。结合美国陆军酒精和药物管制官员 (ADCO) 以及军事心理学家专家的意见,将开发一个多组件、基于网络的分发渠道原型,并填充有关基于证据的工作场所的信息预防规划。这些组件的可行性和实用性将在目前为新兵和年轻成年陆军人员服务的 ADCO 中进行焦点小组测试,测试这些组件在促进基于证据的计划的 DAIS 方面的实用性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher Williams其他文献

Christopher Williams的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher Williams', 18)}}的其他基金

Using Digital Health Technology to Prevent Bullying and Cyberbullying among Elementary School Students
利用数字健康技术预防小学生欺凌和网络欺凌
  • 批准号:
    10822435
  • 财政年份:
    2023
  • 资助金额:
    $ 12.52万
  • 项目类别:
Effect of CX4945 in tamoxifen resistant BCa
CX4945 在他莫昔芬耐药 BCa 中的作用
  • 批准号:
    10673636
  • 财政年份:
    2020
  • 资助金额:
    $ 12.52万
  • 项目类别:
Effect of CX4945 in tamoxifen resistant BCa
CX4945 在他莫昔芬耐药 BCa 中的作用
  • 批准号:
    10228560
  • 财政年份:
    2020
  • 资助金额:
    $ 12.52万
  • 项目类别:
Effect of CX4945 in tamoxifen resistant BCa
CX4945 在他莫昔芬耐药 BCa 中的作用
  • 批准号:
    10458662
  • 财政年份:
    2020
  • 资助金额:
    $ 12.52万
  • 项目类别:
An Evidence-based Approach for Bullying Prevention
预防欺凌的循证方法
  • 批准号:
    10192438
  • 财政年份:
    2020
  • 资助金额:
    $ 12.52万
  • 项目类别:
A High School Program for Preventing Prescription Drug Abuse
预防处方药滥用的高中计划
  • 批准号:
    9980826
  • 财政年份:
    2017
  • 资助金额:
    $ 12.52万
  • 项目类别:
A High School Program for Preventing Prescription Drug Abuse
预防处方药滥用的高中计划
  • 批准号:
    10226253
  • 财政年份:
    2017
  • 资助金额:
    $ 12.52万
  • 项目类别:
Induction of a tumor-hostile breast cancer microenvironment by metformin
二甲双胍诱导肿瘤不利的乳腺癌微环境
  • 批准号:
    8855851
  • 财政年份:
    2015
  • 资助金额:
    $ 12.52万
  • 项目类别:
Induction of a tumor-hostile breast cancer microenvironment by metformin
二甲双胍诱导肿瘤不利的乳腺癌微环境
  • 批准号:
    9058123
  • 财政年份:
    2015
  • 资助金额:
    $ 12.52万
  • 项目类别:
Innovative Positive Juvenile Justice Tools for Youth Courts
青年法庭创新的积极少年司法工具
  • 批准号:
    8713202
  • 财政年份:
    2014
  • 资助金额:
    $ 12.52万
  • 项目类别:

相似国自然基金

源于随机行人碰撞事故边界反求的头部损伤评价准则及风险预测
  • 批准号:
    52372348
  • 批准年份:
    2023
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
核电厂严重事故后放射性碘的传质与化学过程协同演化机理研究
  • 批准号:
    12375176
  • 批准年份:
    2023
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
冷却剂丧失事故下环形燃料重定位与局部热聚焦机理研究
  • 批准号:
    12375172
  • 批准年份:
    2023
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
驾驶行为随机异变下的交通事故风险演化规律解析与建模
  • 批准号:
    52372337
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
面向高速公路互通立交分流区的实时事故风险评估及动态换道路径优化
  • 批准号:
    52302429
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Effect of Emergency Department and After-Emergency Department Analgesic Treatment on Pediatric Long Bone Fracture Outcomes
急诊科和急诊科术后镇痛治疗对小儿长骨骨折预后的影响
  • 批准号:
    10410483
  • 财政年份:
    2018
  • 资助金额:
    $ 12.52万
  • 项目类别:
The Effect of Emergency Department and After-Emergency Department Analgesic Treatment on Pediatric Long Bone Fracture Outcomes
急诊科和急诊科术后镇痛治疗对小儿长骨骨折预后的影响
  • 批准号:
    9764396
  • 财政年份:
    2018
  • 资助金额:
    $ 12.52万
  • 项目类别:
The Effect of Emergency Department and After-Emergency Department Analgesic Treatment on Pediatric Long Bone Fracture Outcomes
急诊科和急诊科术后镇痛治疗对小儿长骨骨折预后的影响
  • 批准号:
    10174978
  • 财政年份:
    2018
  • 资助金额:
    $ 12.52万
  • 项目类别:
Designer covalent heterobivalent inhibitors to prevent IgE-dependent allergic reactions
设计共价异二价抑制剂来预防 IgE 依赖性过敏反应
  • 批准号:
    10553716
  • 财政年份:
    2014
  • 资助金额:
    $ 12.52万
  • 项目类别:
Unobtrusive measurement of sleep disordered breathing in the home
在家中对睡眠呼吸障碍进行不显眼的测量
  • 批准号:
    8629561
  • 财政年份:
    2010
  • 资助金额:
    $ 12.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了